Does This Brain Drink Help You Leave Work Earlier? - Hims & Hers Health (NYSE:HIMS)

Interested in investing in TruBrain's campaign? Click here to get started!

In our more remote, information-driven economy, efficiency and value creation are prized over the 1990s office model of 9 to 5 coffee-driven meetings and water cooler gossip. As a remote worker who writes for a living, I need long periods of deep work, when I can be both efficient and creative. TruBrain has helped me crack the code.

TruBrain recognizes that most people today - regardless of their work - want to have healthy boundaries between their career and personal life so that they can put time into meaningful activities that matter most to them. The company is looking to help these people by providing drinks and edible products that nourish the brain and increase efficiency.

Already over 90% of employees want a job that’s part or full-time remote - saying it allows better work/life balance - but achieving a productive flow state poses a real challenge for many people. The internet - with its continuous notifications and diversions - is the greatest source of distraction for most people. This kills efficiency, as brain science tells us that it can take as much as 23 minutes to return to a proper flow state after we’ve been distracted.

Chugging a cup of coffee, blocking youtube, and locking yourself out of Twitter might be strategies that help some people deal with shallow work, but cutting-edge efficiency requires sustained focused concentration. That’s where TruBrain products come in - its ketone and nootropics products fuel the brain for its best thinking, giving it the nutrition it needs for concentration and focus.

Finding the Brain Food That Works for You

TruBrain primarily produces brain foods, though it has a variety of products. Tackling workplace stress - which over 90% experience at work - TruBrain has developed wearable tech that uses vibrotherapy in an effort to destress America’s workforce.

Meanwhile, its custom drinks include various nootropics - as part of a $3.3 billion industry. Nootropics are natural or synthetic cognitive enhancers that increase concentration, creativity, memory, and brain growth. Caffeine is a basic nootropic, which works by blocking the drowsiness receptors in the brain - however, TruBrain’s drinks harness a host of healthy ingredients to power the brain for clearness and creativity.

Its tasty drinks are based on various formulas combine to make a fully customized product line. TruBrain provides its personalized drinks package because it knows that each individual brain is influenced by a combination of unique genetic and external factors. The package currently offers a variety of 7 nootropics drinks designed to maximize mental performance. The range of the drinks means that you can tailor consumption based on your unique brain to perform at your best, regardless of the situation.

TruBrain is a grassroots company with over 2000 individual investors. Profitable since 2019 as a company, TruBrain looks to advance in the direct-to-consumer market, with comparables in the space like successful companies Hims (NYSE:HIMS), RXBar, and EAS. With over $18 million in lifetime sales, it is currently raising funds through a new round of investing – will TruBrain become another great direct-to-consumer winner? Want to find out how to invest in TruBrain? Click here.

To learn more about TruBrain, visit its website.

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Photo by David Willey

Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.

TruBrain's Reg A+ offering is made available through StartEngine Primary, LLC, member FINRA /SIPC.This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view TruBrain's offering circular and risks associated with this offering.

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

HIMSHims & Hers Health Inc

$37.03-0.38%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.